Consult these resources from our team of experts
Articles
- PDF Meeting The Challenges Of Pediatric Adherence With Patient-Centric Formulations
- PDF Combining Patient Centricity And Commercial Viability In Pediatric Product Development
- PDF Nitrosamine Mitigation: A Path to Regulatory Compliance
- PDF Pediatric Drug Development Trends
- PDF A New Framework for Identifying Nitrosamine Risks and Efficiently Derisking Products
- PDF Customized Release Through Dispersed Dosage Formats: Driving Patient Acceptance and Therapeutic Performance
- PDF Interactive Brochure PDF
- PDF Nitrosamine Impurities Deadline: Are Your Products Compliant?
- PDF Streamline Early-Stage Development to Reach the Clinic Faster
- PDF Solubility Enhancement Of Itraconazole By Amorphous Solid Dispersion Approach Using Spray Drying
- PDF Overcoming The Challenges Of Pediatric Formulation
- PDF Maintaining a Drug’s Bioavailability and Masking Taste With Microencapsulation
- PDF Taste Masking 101: A Q&A With The Experts
- PDF Microspheres Help Fill An Unmet Need In Long-Acting Contraceptives
- PDF Managing Poor Solubility with Cutting-Edge Formulation Approaches
- PDF Taste Masking 101: Optimize Taste and Improve Patient Outcomes
- PDF Formulation Considerations for Pediatric Populations: Finding the Right Dosage Form for Better Adherence
- PDF Path Towards Efficient Pediatric Formulation Development
- PDF How to Achieve Precise and Flexible Dosing with Multiparticulates
- PDF Probing the Source of an Unstable Impurity and Controlling Its Formation at Release
- PDF Dedicated Dialogue: Improved Drug Delivery with Precision Particle Fabrication
- PDF Dissolution Development of Parvulet® Technology Oral Tablets Scientific Briefing
- PDF Formulation of Monodisperse Controlled-Release Quetiapine Microspheres Nonoyama Scientific Briefing
- PDF Formulation of Aqueous Core Poly(lactic acid) Microcapsules N. Dormer Scientific Briefing
- PDF Microcaps® Expanding Solutions for Challenging APIs Through Coacervation White Paper
Case Studies
- PDF Case Study: From Risk To Resolution: A Groundbreaking Approach To Nitrosamine Mitigation
- PDF Case Study: Overcoming Barriers to Patient Adherence with a Novel Dosage Form
- PDF Case Study: Meeting An Aggressive Go-To-Clinic Timeline
- PDF Case Study: Creating a Taste Masked and Easily Swallowed Malaria Drug for Elderly Patients
- PDF Case Study: An Easy-To-Swallow Depression Drug For Elderly Patients
- PDF Case Study: Stable Microcaps® Formulation Masks Bitter HIV Drug for Young Children
- PDF Case Study: Dry Syrup Formulation Masks Bitter Taste in Easy-to-Swallow Suspension
- PDF Microcaps® Outperforms Standard Bead Intermediate Formulations
- PDF Finding Impurities and Controlling Formations at Release
- PDF Case Study: Microcaps® Exceeds Stringent Requirements Beyond Taste Masking
- PDF Case Study: Zenpep-MMTS™ Minitabs Delivers Child-Friendly Dosing for Toddlers
Webinars
- Webinar From Ambiguity To Action: The FDA’s New Nitrosamine Guidance
- Webinar VIDEO: Advances in Oral GLP-1 Analogs for Obesity: Market Insights, Challenges, and Delivery Strategies
- Webinar Optimizing Pediatric Product Development For Commercialization Success
- Webinar Oral Solid Dose Manufacturing For Pediatrics And Other Special Patient Populations
- Webinar Nitrosamine Impurities Deadline: Are Your Products Compliant?
- Webinar Early Stage Pharmaceutical Product Development to Reach the Clinic Faster
- Webinar Selecting a CDMO: A Guide to Successful Collaboration
- Webinar Effective Strategies For Pediatric Formulation Development
- Webinar Taste Masking 101 (Session 4 of 4): Sensory and Performance Evaluation
- Webinar Integrated Solutions From Start to Finish: Outsourced Pharma March 2022
- Webinar Taste Masking 101 (Session 3 of 4): Challenges with Pediatric Flavors for Taste Enhancement & Modulation
- Webinar Injectable Drug Delivery Market
- Webinar Strategies for Effective Patient-Centric Dosage Formulations
- Webinar Taste Masking 101 (Session 2 of 4): Applications and Technologies
- Webinar Taste Masking 101 (Session 1 of 4): Optimize Taste and Improve Patient Treatment Outcomes
- Webinar Minitablets – a Patient Centric Dosage Form
- Webinar Formulation & Drug Development Trends
- Webinar On-Demand Webinar: Patient Adherence for Isolated Populations During the Pandemic
- Webinar Advancing Medication Adherence for Pediatrics and Patients with Dysphagia
- Webinar Life Cycle Management Strategies for Patients with Swallowing Disorders
Videos
- Video Adare Headquarters Ribbon Cutting Ceremony
- Video Saving Patients’ Lives: Sharon’s Story
- PDF Pessano Facility Tour
- Video Pharmaceutical Outsourcing: A Solid Dosage Future
- Video Pharmaceutical Outsourcing: Adare Profile Video
- Video Adare Corporate Video
- Video ADARE Virtual Tour – Vandalia, OH
- Video ADARE Technologies
- Video Giant-A86 Blister Packaging Line
- Video #ChatsWithChaudhrey with Adare Pharma Soutions, CEO, Vivek Sharma on their acquisition on Frontida BioPharma
- Video AdvaTab® Technology
- Video Diffucaps® Technology
- Video Microcaps® Technology
- Video Minitabs™ Technology
- Video Parvulet® Technology
- Video Virtual Tour Teaser
- Video Access to Choice: Long Acting Injectables for Contraceptives BBC Final Video
- Video CPhI Festival of Pharma Roundtable
Leadership Interviews
- Video CPHI Milan 2024: An Interview with Adare CEO Tom Sellig
- PDF Drug Development & Delivery – Tom Sellig Executive Interview
- Video Evolving to Meet the Future Needs of Customers: Interview with Adare CEO Tom Sellig
- Audio Being A Life Sciences Leader interview with Tom Sellig
- PDF Global Business Report Interviews CEO Tom Sellig
- PDF Harris Williams Discusses Growth With the CEO of Adare Pharma Solutions
- PDF The Evolution Of A CDMO
- Video CEO Tom Sellig Interview With Life Science Marketing Radio
- PDF The Journey To Become A Full-Service Provider: An Interview With Adare CEO Tom Sellig
- Audio CEO of Adare Pharma, Tom Sellig, Articulating Core Values During a High-Stakes Interview
- PDF A New End-To-End CDMO Takes Shape: What Does Adare’s Acquisition of Frontida Mean for the Industry?
Speaker Presentations
2024
- PDF From Ambiguity To Action: The FDA’s New Nitrosamine Guidance
- PDF Sprinkle on Soft Food Formulations: An Easy-to-Swallow Dosage Format with Dose Flexibility
- PDF Development of Age-Appropriate Patient-Centric Easy-To-Swallow Novel Dosage Form For Dysphagia and Special Patient Populations
- PDF Assessment of Choking Hazard of an Age-appropriate Patient-centric Novel Dosage Form Designed to Minimize Choking Hazards in Special Patient Populations
- PDF Drug Delivery and Formulation Summit – Breaking the Barriers of Pediatric Development
- PDF Controlled Release Society – A Patient-Centric Approach for Chronotherapy
- PDF CPHI North America – Enhancing Acceptance & Adherence in Special Patient Populations
- Video Technology Challenge: Which Drug Delivery Technologies Should You Know About in 2024
- Video Key Drug Delivery News and Views from 2024 from Your Partners C-Suite
- Audio Navigating Nitrosamine Impurities with Jason Brown
- Video Outsourced Pharma Capacity Update 2024 – Uli Foley Presentation
- Video Enhancing Acceptance and Adherence in Special Patient Populations
2023
- PDF Symposium of Drug Delivery Systems – Use of Multiparticulates and Associated Technologies for Drug Formulation and Development
- PDF Drug Delivery and Formulation Summit – The Perfect Match Between Patient Needs and Optimized Manufacturing
- PDF CPHI North America – A Guide to Successful Collaboration: Considerations When Choosing Your First CDMO as a Start-Up
- PDF CPHI Korea – The Art of Improving Medication Acceptance in Pediatrics: Making Medicines Taste Better
- PDF Partnership Opportunities in Drug Delivery – Multiparticulates: A Versatile Tool for Patient-Centric Fixed Dose Combination Applications
- PDF Controlled Release Society – Harmonizing Medication Delivery with the Body’s Natural Rhythms
- PDF American Association of Pharmaceutical Scientists – Precision Microspheres: Then & Now
- Video Outsourced Pharma Capacity Update 2023 – Renard Jackson Presentation
2022
2020
- PDF Orally-Disintegrating Dosage Forms With Taste Masked Multiparticulates
- PDF Pharma Synergy Presentation
- PDF Taste-Masked Dosage Form for Pediatric Oral Delivery: An Industrial Perspective
- PDF Innovations in Dosage Form Design: Pediatrics & Patients with Dysphagia
- PDF Functional Release Multiparticulates Slam: Can the young Optimµm® technology challenge established Microcaps® and Würster coating technologies?
- PDF Long-Acting Injectables: Stratµm™
- PDF Patient-Centric Dosage Forms: Strategies for Acceptance and Adherence in Pediatric and Geriatric Population
